Faculty Member – Rachael McCaleb

Rachael McCaleb,  PharmD, BCPS

Assistant Professor

Pharmacy Practice
Phone: (501) 603-1418
Fax: (501) 686-7357
Office: Ed II 6/134D
Email: rmccaleb@uams.edu

Education & Training

Postgraduate Year One Pharmacy Residency, Georgia Regents Medical Center/University of Georgia College of Pharmacy, 2014-2015

Doctor of Pharmacy, University of Arkansas for Medical Sciences College of Pharmacy, Little Rock, Arkansas, 2010-2014

Bachelor of Science in Biology, Arkansas State University, Jonesboro, Arkansas, 2005-2009

Teaching Responsibilities

PHPR 3612 – Drug Information History of Drug Information, Nomenclature/FDA Approval Process, Off Label Drug Use, Tertiary Literature Sources, Secondary Literature Sources, Primary Literature Sources, Article Anatomy, Internet Sources/Apps for DI, Systematic Approach to Answering DI Request, Adverse Drug Reaction and Reporting (12 hours)

PHPR 4625 – Therapeutics I Chronic Kidney Disease (CKD) – Progression Modifying Therapies, CKD – Management of Complications, Benign Prostatic Hyperplasia, Erectile Dysfunction, Urinary Incontinence (5-hours)

PHPR 5733 – Pharmacy Management Managed Care Pharmacy (1-hour)

Clinical Practice

Clinical Specialist, Internal Medicine Team 3A – Univeristy of Arkansas for Medical Sciences Medical Center, Little Rock, AR

Research & Scholarly Interests 

Proton pump inhibitor use and adverse events

Memberships 

American Association of Colleges of Pharmacy (AACP)

 

Publications 

Book Contributions
Olsen, Keith M and McCaleb Rachael V. Evaluation of the Gastrointestinal Tract. Chapter e31. In: Pharmacotherapy: a pathophysiologic approach. Editors Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey. 10th edition New York: McGraw-Hill Education; 2017. P433.

Peer-Reviewed
McCaleb R. Emerging therapies for Clostridium difficile infection. J Pharm Pharmaceutics. 2017; 4(2):172- 178.

McCaleb RV, Clemmons AB, Clark S, Gandhi AS. Clinical outcomes of proton pump inhibitor use in hematology/oncology patients at an academic medical center. Ann Pharmacother. 2016 Jul;50(7):541-7.

Campbell C, McCaleb R, Manasco KB. New Inhaled Antimicrobial Formulations for Use in the Cystic Fibrosis Patient Population. Ann Pharmacother. 2016 Feb;50(2):133-40.

McCaleb R, Maples H, Warren R, Willis D, O’Brien CE. Description of respiratory microbiology of children with long-term tracheostomies. Respir Care. 2016 Apr;61(4):447-52.

Curriculum Vitae